Cargando…

Corrigendum: Tanshinone IIA Inhibits Epithelial-to-Mesenchymal Transition Through Hindering β-Arrestin1 Mediated β-Catenin Signaling Pathway in Colorectal Cancer

Detalles Bibliográficos
Autores principales: Song, Qing, Yang, Liu, Han, Zhifen, Wu, Xinnan, Li, Ruixiao, Zhou, Lihong, Liu, Ningning, Sui, Hua, Cai, Jianfeng, Wang, Yan, Ji, Qing, Li, Qi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284105/
https://www.ncbi.nlm.nih.gov/pubmed/35847033
http://dx.doi.org/10.3389/fphar.2022.929656
_version_ 1784747486569562112
author Song, Qing
Yang, Liu
Han, Zhifen
Wu, Xinnan
Li, Ruixiao
Zhou, Lihong
Liu, Ningning
Sui, Hua
Cai, Jianfeng
Wang, Yan
Ji, Qing
Li, Qi
author_facet Song, Qing
Yang, Liu
Han, Zhifen
Wu, Xinnan
Li, Ruixiao
Zhou, Lihong
Liu, Ningning
Sui, Hua
Cai, Jianfeng
Wang, Yan
Ji, Qing
Li, Qi
author_sort Song, Qing
collection PubMed
description
format Online
Article
Text
id pubmed-9284105
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-92841052022-07-16 Corrigendum: Tanshinone IIA Inhibits Epithelial-to-Mesenchymal Transition Through Hindering β-Arrestin1 Mediated β-Catenin Signaling Pathway in Colorectal Cancer Song, Qing Yang, Liu Han, Zhifen Wu, Xinnan Li, Ruixiao Zhou, Lihong Liu, Ningning Sui, Hua Cai, Jianfeng Wang, Yan Ji, Qing Li, Qi Front Pharmacol Pharmacology Frontiers Media S.A. 2022-07-01 /pmc/articles/PMC9284105/ /pubmed/35847033 http://dx.doi.org/10.3389/fphar.2022.929656 Text en Copyright © 2022 Song, Yang, Han, Wu, Li, Zhou, Liu, Sui, Cai, Wang, Ji and Li. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Song, Qing
Yang, Liu
Han, Zhifen
Wu, Xinnan
Li, Ruixiao
Zhou, Lihong
Liu, Ningning
Sui, Hua
Cai, Jianfeng
Wang, Yan
Ji, Qing
Li, Qi
Corrigendum: Tanshinone IIA Inhibits Epithelial-to-Mesenchymal Transition Through Hindering β-Arrestin1 Mediated β-Catenin Signaling Pathway in Colorectal Cancer
title Corrigendum: Tanshinone IIA Inhibits Epithelial-to-Mesenchymal Transition Through Hindering β-Arrestin1 Mediated β-Catenin Signaling Pathway in Colorectal Cancer
title_full Corrigendum: Tanshinone IIA Inhibits Epithelial-to-Mesenchymal Transition Through Hindering β-Arrestin1 Mediated β-Catenin Signaling Pathway in Colorectal Cancer
title_fullStr Corrigendum: Tanshinone IIA Inhibits Epithelial-to-Mesenchymal Transition Through Hindering β-Arrestin1 Mediated β-Catenin Signaling Pathway in Colorectal Cancer
title_full_unstemmed Corrigendum: Tanshinone IIA Inhibits Epithelial-to-Mesenchymal Transition Through Hindering β-Arrestin1 Mediated β-Catenin Signaling Pathway in Colorectal Cancer
title_short Corrigendum: Tanshinone IIA Inhibits Epithelial-to-Mesenchymal Transition Through Hindering β-Arrestin1 Mediated β-Catenin Signaling Pathway in Colorectal Cancer
title_sort corrigendum: tanshinone iia inhibits epithelial-to-mesenchymal transition through hindering β-arrestin1 mediated β-catenin signaling pathway in colorectal cancer
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284105/
https://www.ncbi.nlm.nih.gov/pubmed/35847033
http://dx.doi.org/10.3389/fphar.2022.929656
work_keys_str_mv AT songqing corrigendumtanshinoneiiainhibitsepithelialtomesenchymaltransitionthroughhinderingbarrestin1mediatedbcateninsignalingpathwayincolorectalcancer
AT yangliu corrigendumtanshinoneiiainhibitsepithelialtomesenchymaltransitionthroughhinderingbarrestin1mediatedbcateninsignalingpathwayincolorectalcancer
AT hanzhifen corrigendumtanshinoneiiainhibitsepithelialtomesenchymaltransitionthroughhinderingbarrestin1mediatedbcateninsignalingpathwayincolorectalcancer
AT wuxinnan corrigendumtanshinoneiiainhibitsepithelialtomesenchymaltransitionthroughhinderingbarrestin1mediatedbcateninsignalingpathwayincolorectalcancer
AT liruixiao corrigendumtanshinoneiiainhibitsepithelialtomesenchymaltransitionthroughhinderingbarrestin1mediatedbcateninsignalingpathwayincolorectalcancer
AT zhoulihong corrigendumtanshinoneiiainhibitsepithelialtomesenchymaltransitionthroughhinderingbarrestin1mediatedbcateninsignalingpathwayincolorectalcancer
AT liuningning corrigendumtanshinoneiiainhibitsepithelialtomesenchymaltransitionthroughhinderingbarrestin1mediatedbcateninsignalingpathwayincolorectalcancer
AT suihua corrigendumtanshinoneiiainhibitsepithelialtomesenchymaltransitionthroughhinderingbarrestin1mediatedbcateninsignalingpathwayincolorectalcancer
AT caijianfeng corrigendumtanshinoneiiainhibitsepithelialtomesenchymaltransitionthroughhinderingbarrestin1mediatedbcateninsignalingpathwayincolorectalcancer
AT wangyan corrigendumtanshinoneiiainhibitsepithelialtomesenchymaltransitionthroughhinderingbarrestin1mediatedbcateninsignalingpathwayincolorectalcancer
AT jiqing corrigendumtanshinoneiiainhibitsepithelialtomesenchymaltransitionthroughhinderingbarrestin1mediatedbcateninsignalingpathwayincolorectalcancer
AT liqi corrigendumtanshinoneiiainhibitsepithelialtomesenchymaltransitionthroughhinderingbarrestin1mediatedbcateninsignalingpathwayincolorectalcancer